Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611385 · ClinicalTrials.gov registry record
Amphetamine Induced Adult Respiratory Distress Syndrome
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 49
- Enrollment target
NCT05611385 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 49 participants.
The verdict
NCT05611385 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Methamphetamine and amphetamine has various cardiovascular and central nervous system effects. Long-term use is associated with many adverse health effects including cardiomyopathy, hemorrhagic, and ischemic stroke. Death is usually caused by cardiovascular collapse and while amphetamine abuse has been considered as a potential cause of acute respiratory distress syndrome, the reports are usually anecdotal. This investigation considers reviewing individuals with few to zero medical conditions who develop acute respiratory distress syndrome and are methamphetamine positive
Interventions
- OTHER Difference in development of Acute Lung Injury in Amphetamine positive and negative patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05611385
The ClinicalTrials.gov registry entry for NCT05611385 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arrowhead Regional Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Difference in development of Acute Lung Injury in Amphetamine positive and negative patients is the first listed.
NCT05611385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05611385 about?
NCT05611385 is a clinical study titled "Amphetamine Induced Adult Respiratory Distress Syndrome". Methamphetamine and amphetamine has various cardiovascular and central nervous system effects. Long-term use is associated with many adverse health effects including cardiomyopathy, hemorrhagic, and ischemic stroke. Death is usually caused by cardiovascular collapse and while amphetamine abuse has b...
What is the current status of trial NCT05611385?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2019-01-01. Estimated completion is 2020-01-01.
What interventions are being tested in trial NCT05611385?
The interventions under investigation include: Difference in development of Acute Lung Injury in Amphetamine positive and negative patients (OTHER).
Who is sponsoring clinical trial NCT05611385?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.